Uro-Vaxom, capsules 6 mg 30 pcs
€47.34 €39.45
Uro-Vaxom has the following effects: stimulates T-lymphocytes: induces formation of endogenous interferon; increases the content of immunoglobulin A (IgA), including in urine.
Uro-Vaxom reduces the frequency of recurrent urinary tract infections, especially cystitis.
Indications
Combined treatment and prevention of recurrence of chronic urinary tract infections, especially cystitis, regardless of the nature of the microorganism, in combination with antibiotics or antiseptics in adults and children from 4 years of age.
Composition
How to take, the dosage
Treatment: 1 capsule daily in the morning on an empty stomach as an adjunctive medication in case of conventional antimicrobial therapy until symptoms disappear, but not less than 10 days. Maximum duration of treatment is 3 months.
Prevention of recurrence of chronic urinary tract infection: 1 capsule daily in the morning on an empty stomach for 3 months.
If the child has difficulty in swallowing the capsule, it should be opened and the contents mixed with a drink (fruit juice, milk, etc.).
The duration of treatment or the prescription of repeated therapy should be determined by the doctor, based on the state of health of the patient.
Interaction
Interaction with other medicinal products has not yet been established.
As a precautionary measure, the drug should not be used two weeks before and two weeks after oral administration of live vaccines.
Immunosuppressive drugs may affect the effect of the drug.
Contraindications
Hypersensitivity to the components of Uro-Vaxom.
Side effects
Significant gastrointestinal disorders (diarrhea, nausea, vomiting), skin reactions (itching, exanthema, erythema) and limited allergic skin reactions may occur in individuals. Rarely – a slight fever.
In case of more severe complications, treatment should be discontinued and the doctor should be consulted.
Overdose
There are no reports of overdose.
The nature of the drug Uro-Vaxom and the results of its toxicity study indicate that overdose is unlikely.
Pregnancy use
Clinical studies have not been conducted on pregnant women.
Animal studies showed no negative effects on pregnancy, embryo, fetal and/or postnatal development.
There have been no specific studies on breastfeeding and no data are available to date.
Weight | 0.025 kg |
---|---|
Shelf life | 5 years |
Conditions of storage | At 15-25 °C |
Manufacturer | OM Pharma, Switzerland |
Medication form | capsules |
Brand | OM Pharma |
Related products
Buy Uro-Vaxom, capsules 6 mg 30 pcs with delivery to USA, UK, Europe and over 120 other countries.